Moreover, TAM-secreted CCL22 can activate FAK, which subsequently mediates the phosphorylation of Gli1 at specific residues, boosting Gli1’s transcriptional activity and propelling ESCC progression. Here, GLI1 is linked to esophageal squamous cell carcinoma.